HGH is a peptide, specifically a 191-amino acid protein hormone. So is sermorelin, at 29 amino acids. The difference that matters is not peptide versus not-peptide. It is whether the molecule delivers growth hormone or tells your pituitary to release its own.
HGH is a peptide. It is a 191-amino acid single-chain protein hormone made by the pituitary, and a protein is simply a large peptide. It is not a steroid. The confusion behind the question comes from a naming habit in the wellness market, where the word "peptides" has come to mean the small compounds like sermorelin, ipamorelin, and CJC-1295. Those are peptides too. They just do something different from HGH, and that difference is the whole point.
- HGH, or somatropin, is a 191-amino acid single-chain protein hormone. It is a peptide, not a steroid.
- Sermorelin is a 29-amino acid GHRH analog. It signals the pituitary to release GH rather than delivering it [1].
- The small GH peptides work one step upstream, so somatostatin feedback stays active and the pituitary is not bypassed [2].
- CJC-1295 is a long-acting GHRH analog with a half-life of 5.8 to 8.1 days [3]; ipamorelin is a selective secretagogue on the ghrelin receptor [4].
- Injected HGH raises GH whether the pituitary agrees or not; the GH peptides cannot push output past what the pituitary can physiologically make [2].
- None of the compounded GH peptides is FDA-approved, and all sit on the WADA prohibited list [7][8].
Yes, HGH Is a Peptide. Here Is the Precise Answer
Peptides and proteins are the same class of molecule: chains of amino acids linked by peptide bonds. The line between them is length, and it is a soft one. Chains up to roughly 40 to 50 amino acids are usually called peptides, and longer chains are called proteins. HGH sits at 191 amino acids, so it is a protein, and a protein is a large peptide. Calling HGH a peptide is correct. Calling it a steroid is not.
Steroids are a different chemistry entirely. They are lipid ring molecules derived from cholesterol, and they cross the cell membrane to bind receptors inside the cell. HGH and the GH peptides are amino acid chains that bind receptors on the cell surface. That is also why HGH cannot be taken as a pill. Digestion breaks the protein apart before it reaches the blood, so it has to be injected. The same is true of sermorelin.
Where the Confusion Comes From: HGH vs the GH Peptides
The market split one word into two meanings. "HGH" came to mean the actual growth hormone molecule, injected directly as recombinant somatropin. "Peptides" became shorthand for the small compounds that make your own pituitary release HGH. Both are peptides by chemistry. The useful distinction is not peptide versus not-peptide. It is deliver-the-hormone versus signal-the-gland.
Sermorelin is the clearest example of the second group. It is a 29-amino acid analog of growth hormone-releasing hormone, the same signal the hypothalamus uses to tell the pituitary to release GH [1]. It does not contain growth hormone. It contains the instruction.
| HGH (somatropin) | GH peptides (sermorelin, CJC-1295, ipamorelin) | |
|---|---|---|
| Molecule | 191-amino acid protein | Short peptides, 29 amino acids or fewer [1] |
| What it does | Delivers growth hormone directly | Signal the pituitary to release its own GH [1][2] |
| Feedback control | Bypasses somatostatin feedback | Somatostatin feedback stays active [2] |
| Route | Subcutaneous injection | Subcutaneous injection |
| Is it a steroid? | No, a protein hormone | No, amino acid peptides |
How the GH Peptides Actually Work
They act one step upstream of HGH. Sermorelin and CJC-1295 bind the GHRH receptor on the pituitary, and ipamorelin binds the ghrelin receptor. Different doors, same result: a pulse of the body's own growth hormone [3][4]. The largest of those pulses naturally occurs during slow-wave sleep, which is why these peptides are dosed at bedtime [5].
The mechanism is what drives the safety difference. Because the signal runs through the pituitary, somatostatin feedback still applies and output stays limited to what the gland can physiologically make [2]. Injected HGH has no such ceiling. That is the practical reason a clinician reaches for a GH peptide before exogenous HGH in age-related decline.
- Sermorelin and CJC-1295: GHRH-receptor analogs that mimic the natural GH-releasing signal [1][3]
- Ipamorelin: a selective ghrelin-receptor secretagogue that adds a second release signal without raising cortisol or prolactin [4]
- CJC-1295 carries an albumin-binding group that stretches its half-life to 5.8 to 8.1 days [3]
- All of them depend on a working pituitary; none delivers growth hormone itself
If HGH and Sermorelin Both Raise GH, Which Should You Ask About?
For age-related GH decline with a functional pituitary, a GH peptide like sermorelin is the usual starting point, not injected HGH. It restores the body's own pulsatile release, a GHRH analog raised GH and IGF-1 in older adults on a nightly protocol [6], and it does so without the oversaturation risk that comes from bypassing feedback [2]. Injected HGH is reserved for diagnosed pituitary insufficiency, where the gland cannot respond to the signal.
Cost and access separate them too. HGH is a brand-name biologic. Sermorelin is compounded by licensed 503A and 503B pharmacies, which is why it is the accessible GH option through telehealth. It also carries the honest caveat that compounded peptides are not FDA-approved [7], and any GH-axis peptide is banned in tested sport [8].
Whether the plan is HGH or a GH peptide, a baseline IGF-1 draw comes first. It is the number that tells a prescriber whether the GH axis is actually low, and at the 90-day retest whether treatment moved it. A program that prescribes either one without it is skipping the measurement that makes the decision.
HGH is a biologic reserved for diagnosed deficiency. For age-related decline, a GHRH-analog peptide like sermorelin is the usual starting point, and it only makes sense measured against a baseline IGF-1. SystemLabs tests IGF-1 before prescribing and formulates from licensed U.S. pharmacies, so the GH axis gets a real starting number rather than a guess.
Frequently Asked Questions
Is HGH a peptide or a steroid?
HGH is a peptide, specifically a 191-amino acid protein hormone made by the pituitary. It is not a steroid. Steroids are lipid ring molecules derived from cholesterol; HGH is a chain of amino acids that binds a receptor on the cell surface, which is also why it has to be injected rather than swallowed.
Is sermorelin the same as HGH?
No. Sermorelin is a 29-amino acid GHRH analog that signals the pituitary to release its own growth hormone [1]. HGH is the 191-amino acid hormone itself, injected directly. Sermorelin preserves somatostatin feedback, while injected HGH bypasses it [2].
Are peptides and proteins the same thing?
Chemically, yes. Both are chains of amino acids. The names split by length: chains up to about 40 to 50 amino acids are called peptides, and longer ones are called proteins. HGH at 191 amino acids is a protein, which is a large peptide. Sermorelin at 29 amino acids is squarely a peptide [1].
Do GH peptides contain growth hormone?
No. Sermorelin, CJC-1295, and ipamorelin contain no growth hormone. They carry the signal that tells the pituitary to release its own [1][4]. That is the core difference from injected HGH, which is the hormone itself.
Are HGH peptides FDA-approved?
No compounded GH peptide is FDA-approved. Sermorelin, CJC-1295, and ipamorelin are prepared by compounding pharmacies, and the FDA has flagged several GH-axis peptides among bulk substances that may present compounding safety risks [7]. They are also prohibited in tested sport at all times [8].
Why can't you take HGH or sermorelin as a pill?
Both are peptides, and digestion breaks amino acid chains apart before they reach the bloodstream. That is why growth hormone and its releasing peptides are given by subcutaneous injection rather than by mouth.
References
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency BioDrugs, 1999. PMID: 18031173. https://pubmed.ncbi.nlm.nih.gov/18031173/
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006. PMID: 18046908. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog Endocrinology, 2005. PMID: 15817669. https://pubmed.ncbi.nlm.nih.gov/15817669/
- Ipamorelin, the first selective growth hormone secretagogue European Journal of Endocrinology, 1998. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Growth hormone secretion during sleep Journal of Clinical Investigation, 1968. PMID: 5675428. https://pubmed.ncbi.nlm.nih.gov/5675428/
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology & Metabolism, 1997. PMID: 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Certain bulk drug substances for use in compounding that may present significant safety risks FDA.gov, Human Drug Compounding, 2026. Content current as of 04/22/2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- The 2026 Prohibited List: International Standard, section S2.2.4 growth hormone releasing factors World Anti-Doping Agency, 2026. WADA 2026 Prohibited List. https://www.wada-ama.org/en/resources/2026-prohibited-list
